We have observed an increase of myeloid precursors with suppressive activity, suggesting that the binding of CD200R on myeloid cells could play a role in the development of a leukemia-permissive micro-environment and in the reduction of the anti-infective immune response (personal data, unpublished). Here, CD200R1 is linked to leukemia.